Hepatoblastoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 43: | Line 43: | ||
==Treatment== | ==Treatment== | ||
[[Hepatoblastoma medical therapy|Medical Therapy]] | [[Hepatoblastoma surgery|Surgery]] | [[Hepatoblastoma primary prevention|Primary Prevention]] | [[Hepatoblastoma secondary prevention|Secondary Prevention]] | [[Hepatoblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatoblastoma future or investigational therapies|Future or Investigational Therapies]] | [[Hepatoblastoma medical therapy|Medical Therapy]] | [[Hepatoblastoma surgery|Surgery]] | [[Hepatoblastoma primary prevention|Primary Prevention]] | [[Hepatoblastoma secondary prevention|Secondary Prevention]] | [[Hepatoblastoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatoblastoma future or investigational therapies|Future or Investigational Therapies]] | ||
{{Soft tissue tumors and sarcomas}} | {{Soft tissue tumors and sarcomas}} |
Revision as of 15:26, 18 September 2012
For patient information, click here
Hepatoblastoma | |
CT: Hepatoblastoma. A four year old girl with a history of congenital heart disease. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
ICD-10 | C22.0 |
ICD-O: | 8970/3 |
DiseasesDB | 5799 |
MeSH | D018197 |
Hepatoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatoblastoma On the Web |
American Roentgen Ray Society Images of Hepatoblastoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatoblastoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies